Community
Making the Most of JPM: A Readiness Guide for Life Sciences Companies
Please join us for the latest installment of Cooley Talks Life Sciences. In this quarterly virtual series, we tap into Cooley’s unrivaled network of life sciences thought leaders to discuss key industry developments, challenges, solutions and the road ahead. At Cooley, we don’t just advise – we accelerate your achievements. In this episode, our panel […]
Cooley Talks – Making the Most of JPM: A Readiness Guide for Life Sciences Companies
Please join Cooley for their latest installment of Cooley Talks Life Sciences. In this quarterly virtual series, they tap into Cooley’s unrivaled network of life sciences thought leaders to discuss key industry developments, challenges, solutions and the road ahead. In this episode, the panel will unpack how life sciences companies can make the most of […]
Relaunch of the Northwest/Seattle Chapter of the Association of Bioscience Financial Officers (ABFO)
ABFO is a national networking organization for senior finance leaders across biotechnology, med tech, and the broader life sciences industry, providing a forum to share insights, compare best practices, and build peer networks. It has been several years since the ABFO NW/Seattle area chapter was active, and this event is intended as a fresh kick-off for […]
Biotech Showcase – Virtual Conference
Receive a $200 discount off registration fees with code: supLSW2026 Biotech Showcase, along with its family of events, Seed Showcase and TechBio Showcase, is a dedicated investor conference designed to provide private and micro-mid-cap biotechnology companies with the opportunity to present to and connect with investors and biopharmaceutical executives. With a roster of over 400 […]
Roadmap to Formulation Development of Monoclonal Antibodies and Related Proteins: From Pre-Clinical to Commercialization
A symposium on formulation development of monoclonal antibodies and related proteins will explore the integrated pathway from preclinical phases to full commercialization. Sessions will include the formulation development roadmap, high-throughput screening strategies, first-inhuman (FIH) formulation development, Phase 3 formulation optimization, and commercial drug product design. Experts will discuss how a deep understanding of the end-to-end […]